Advertisement

Ads Placeholder
Loading...

Vimta Labs Limited

VIMTALABS.BOBSE
Healthcare
Medical - Diagnostics & Research
409.15
2.35(0.58%)
Indian Market opens in 34h 8m

Vimta Labs Limited Fundamental Analysis

Vimta Labs Limited (VIMTALABS.BO) shows moderate financial fundamentals with a PE ratio of 24.31, profit margin of 19.04%, and ROE of 19.70%. The company generates $3.9B in annual revenue with moderate year-over-year growth of 8.08%.

Key Strengths

Operating Margin24.19%
PEG Ratio-4.93
Current Ratio3.30

Areas of Concern

Cash Position3.11%
We analyze VIMTALABS.BO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 81.0/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
81.0/100

We analyze VIMTALABS.BO's fundamental strength across five key dimensions:

Efficiency Score

Excellent

VIMTALABS.BO demonstrates superior asset utilization.

ROA > 10%
14.42%

Valuation Score

Excellent

VIMTALABS.BO trades at attractive valuation levels.

PE < 25
24.31
PEG Ratio < 2
-4.93

Growth Score

Excellent

VIMTALABS.BO delivers strong and consistent growth momentum.

Revenue Growth > 5%
8.08%
EPS Growth > 10%
63.50%

Financial Health Score

Excellent

VIMTALABS.BO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
3.30

Profitability Score

Excellent

VIMTALABS.BO achieves industry-leading margins.

ROE > 15%
19.70%
Net Margin ≥ 15%
19.04%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is VIMTALABS.BO Expensive or Cheap?

P/E Ratio

VIMTALABS.BO trades at 24.31 times earnings. This indicates a fair valuation.

24.31

PEG Ratio

When adjusting for growth, VIMTALABS.BO's PEG of -4.93 indicates potential undervaluation.

-4.93

Price to Book

The market values Vimta Labs Limited at 4.36 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.36

EV/EBITDA

Enterprise value stands at 13.07 times EBITDA. This signals the market has high growth expectations.

13.07

How Well Does VIMTALABS.BO Make Money?

Net Profit Margin

For every $100 in sales, Vimta Labs Limited keeps $19.04 as profit after all expenses.

19.04%

Operating Margin

Core operations generate 24.19 in profit for every $100 in revenue, before interest and taxes.

24.19%

ROE

Management delivers $19.70 in profit for every $100 of shareholder equity.

19.70%

ROA

Vimta Labs Limited generates $14.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

14.42%

Following the Money - Real Cash Generation

Operating Cash Flow

Vimta Labs Limited produces operating cash flow of $753.12M, showing steady but balanced cash generation.

$753.12M

Free Cash Flow

Vimta Labs Limited produces free cash flow of $272.07M, offering steady but limited capital for shareholder returns and expansion.

$272.07M

FCF Per Share

Each share generates $6.09 in free cash annually.

$6.09

FCF Yield

VIMTALABS.BO converts 1.48% of its market value into free cash.

1.48%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

24.31

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-4.93

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.36

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.65

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.20

vs 25 benchmark

ROA

Return on assets percentage

0.14

vs 25 benchmark

ROCE

Return on capital employed

0.21

vs 25 benchmark

How VIMTALABS.BO Stacks Against Its Sector Peers

MetricVIMTALABS.BO ValueSector AveragePerformance
P/E Ratio24.3128.45 Better (Cheaper)
ROE19.70%763.00% Weak
Net Margin19.04%-45265.00% (disorted) Strong
Debt/Equity0.020.34 Strong (Low Leverage)
Current Ratio3.302795.60 Strong Liquidity
ROA14.42%-16588.00% (disorted) Strong

VIMTALABS.BO outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Vimta Labs Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

89.26%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

877.98%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

287.17%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ